RT Journal Article
SR Electronic
T1 Nemvaleukin alfa, a novel engineered IL-2 fusion protein, drives antitumor immunity and inhibits tumor growth in small cell lung cancer
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e004913
DO 10.1136/jitc-2022-004913
VO 10
IS 9
A1 Pan, Yuanwang
A1 Hao, Yuan
A1 Han, Han
A1 Chen, Ting
A1 Ding, Hailin
A1 Labbe, Kristen E
A1 Shum, Elaine
A1 Guidry, Kayla
A1 Hu, Hai
A1 Sherman, Fiona
A1 Geng, Ke
A1 Stephens, Janaye
A1 Chafitz, Alison
A1 Tang, Sittinon
A1 Huang, Hsin-Yi
A1 Peng, Chengwei
A1 Almonte, Christina
A1 Lopes, Jared E
A1 Losey, Heather C
A1 Winquist, Raymond J
A1 Velcheti, Vamsidhar
A1 Zhang, Hua
A1 Wong, Kwok-Kin
YR 2022
UL http://jitc.bmj.com/content/10/9/e004913.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.